LUCD (Lucid Diagnostics) Days Inventory: 23.08 (As of Mar. 2026) — 22% Above Median


LUCD Lucid Diagnostics Inc LUCD
26 GF Score
Price $1.07
GF Value $0.81
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Lucid Diagnostics Days Inventory?

Lucid Diagnostics LUCD +4.85% 26 Days Inventory is 23.08 as of Mar. 2026, which is 22% above its 10-year median of 18.99. GuruFocus rates LUCD with a GF Score™ of 26/100 and a GF Value™ of $0.81 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Lucid Diagnostics ranks better than 97.33% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Lucid Diagnostics's Average Total Inventories for the three months ended in Mar. 2026 was $0.41 Mil. Lucid Diagnostics's Cost of Goods Sold for the three months ended in Mar. 2026 was $1.63 Mil. Hence, Lucid Diagnostics's Days Inventory for the three months ended in Mar. 2026 was 23.08.

The historical rank and industry rank for Lucid Diagnostics's Days Inventory or its related term are showing as below:

LUCD' s Days Inventory Range Over the Past 10 Years
Min: 11.87   Med: 18.99   Max: 413.98
Current: 24.86

During the past 7 years, Lucid Diagnostics's highest Days Inventory was 413.98. The lowest was 11.87. And the median was 18.99.

LUCD's Days Inventory is ranked better than
97.33% of 786 companies
in the Medical Devices & Instruments industry
Industry Median: 179.86 vs LUCD: 24.86

Lucid Diagnostics's Days Inventory declined from Mar. 2025 (24.27) to Mar. 2026 (23.08).

Inventory Turnover measures how fast the company turns over its inventory within a year. Lucid Diagnostics's Inventory Turnover for the three months ended in Mar. 2026 was 3.95.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lucid Diagnostics's Inventory-to-Revenue for the three months ended in Mar. 2026 was 0.33.


Lucid Diagnostics  (NAS:LUCD) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lucid Diagnostics's Inventory Turnover for the three months ended in Mar. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lucid Diagnostics's Inventory to Revenue for the three months ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Lucid Diagnostics Days Inventory Related Terms


Lucid Diagnostics Days Inventory Historical Data

* Premium members only.

The historical data trend for Lucid Diagnostics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lucid Diagnostics Days Inventory Chart

Lucid Diagnostics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial 413.98 30.50 11.87 15.91 18.99

Lucid Diagnostics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.27 28.87 26.64 20.58 23.08

LUCD vs TLSI, INFU, TANAF: Days Inventory Comparison

For the Medical Devices subindustry, Lucid Diagnostics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lucid Diagnostics Days Inventory vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lucid Diagnostics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Lucid Diagnostics's Days Inventory falls into.


LUCD
26GF Score
Lucid Diagnostics Inc LUCD
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lucid Diagnostics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lucid Diagnostics's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.341 + 0.353) / 2 ) / 6.67*365
=0.347 / 6.67*365
=18.99

Lucid Diagnostics's Days Inventory for the quarter that ended in Mar. 2026 is calculated as:

Days Inventory (Q: Mar. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0.353 + 0.469) / 2 ) / 1.625*365 / 4
=0.411 / 1.625*365 / 4
=23.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 23.08 mean?
Lucid Diagnostics (LUCD) has a Days Inventory of 23.08 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lucid Diagnostics and its competitors. This is 22% above median its historical median of 18.99. Over the past decade, Lucid Diagnostics' Days Inventory has ranged from 11.87 to 413.98. According to the industry distribution chart, Lucid Diagnostics ranks #21 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 2.7%.
Is Lucid Diagnostics' Days Inventory too high?
Lucid Diagnostics' current Days Inventory of 23.08 is 22% above median its 10-year median of 18.99. Over the past 10 years, this metric has ranged from a low of 11.87 to a high of 413.98. The Medical Devices & Instruments industry median Days Inventory is 179.86. Lucid Diagnostics' value of 23.08 is 87.2% below this industry median. Based on the distribution chart, Lucid Diagnostics ranks #21 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Lucid Diagnostics has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lucid Diagnostics' Days Inventory compare to TLSI and INFU?
According to the Medical Devices & Instruments industry distribution chart, Lucid Diagnostics ranks #21 out of 786 companies for Days Inventory. This places Lucid Diagnostics in the top 3% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.86. Lucid Diagnostics' value of 23.08 is 87.2% below this benchmark. Historically, Lucid Diagnostics' own Days Inventory has ranged from 11.87 to 413.98 over the past decade. While the company's 10-year median is 18.99 vs. the industry median of 179.86, Lucid Diagnostics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.86, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lucid Diagnostics's current Days Inventory of 23.08 is 87.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lucid Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lucid Diagnostics's current Days Inventory is 23.08, which is 22% above median its own 10-year median of 18.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lucid Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Lucid Diagnostics (LUCD) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.81, compared to a current price of $1.07 — trading 31.5% above its estimated fair value. The current Days Inventory is 23.08, which is 22% above median its 10-year median of 18.99 and 87.2% below the Medical Devices & Instruments industry median of 179.86. Lucid Diagnostics' overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Lucid Diagnostics (LUCD), the current Days Inventory is 23.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lucid Diagnostics (LUCD) Overvalued in 2026?

Based on GuruFocus' analysis, Lucid Diagnostics stock appears to be overvalued. The current stock price of $1.07 is trading 31.5% above its estimated GF Value™ of $0.81. GuruFocus considers Lucid Diagnostics to be Significantly Overvalued.

Key valuation signals for LUCD:

  • Days Inventory: 23.08 (22% above median its 10-year median of 18.99)
  • GF Value™: $0.81 vs. price of $1.07 (31.5% above fair value)
  • GF Score™: 26/100 with 5 warning signs
  • Industry Position: 87.2% below the Medical Devices & Instruments median (#21 of 786)

No single metric tells the full story. See the LUCD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lucid Diagnostics Business Description

Address 360 Madison Avenue, 25th Floor, New York, NY, USA, 10017
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
26GF Score

Get the complete analysis for LUCD

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.07
Price
$0.81
GF Value